Produzione VHH tri-specifica Italia

• 

  Optimizing production of tri-specific antibodies for therapeutic use

  Si illustra the versatility of creating tri-specific VHH antibodies and the potential it has for antibody development. With some extra tricks that researchers play with the VHH properties, these antibodies can actually multi-task. This is important because it suggests that a single antibody might treat multiple symptoms.

  
  

• 

  Revolutionizing antibody design with tri-specific VHH technology

  That could have all kinds of applicazioni in medicine. The hopes seem realistic: It could revolutionize our approaches to cancer, sepsis and other devastating diseases. Borrowed from the immune system of llamas, new tri-specific VHH antibodies could go after multiple cancer cells in one and put a stop to multiple kinds of viruses at once, presenting a promising option for healthcare.

  
  

• 

  Streamlining production of multi-functional VHH antibodies

  Le produzione of multi-functional VHH antibodies by Yaohan is extremely efficient and smooth. The researchers are able to engineer and test antibodies using the right phage display technology, which is a crucial step in such a rapidly evolving field of medical research. Their unique way of making such antibodies means they are produced in high volume without sacrificing quality.

  
  

Why choose Yaohai Tri-specific VHH Production?

• Personalizzazione, efficienza e convenienza

  Yaohai Bio-Pharma has experience in manufacturing biologics that are created from microorganisms. We offer bespoke RD solutions as well as manufacturing services while minimising potential risks. We have worked with diverse techniques, such as recombinant cellular subunits, vaccines (including peptides), growth factors, hormones, and the Tri-specific VHH Production. We are a specialist in many microorganisms like yeast extracellular and intracellular secretion (yields up to 15g/L) and bacteria intracellular soluble, and inclusion body (yields up to 10g/L). We have also developed a BSL-2 fermentation platform to create bacterial vaccines. We have a track record of improving production processes, thereby increasing yields and reducing costs. We have a highly-efficient technology team to ensure timely and high-quality delivery of projects. This helps us bring your products that are unique faster to the market.

• Solida catena di fornitura e capacità di produzione

  Yaohai Bio-Pharma, a Tri-specific VHH Production manufacturer of biological products, is a specialist in microbial fermentations. We have built a modern factory equipped with modern facilities and strong RD and manufacturing capabilities. Five drug substance production lines that are compliant with GMP standards for microbial purification and ferment, as well as two fill and finish lines for vials as well as cartridges, as well as needles that are pre-filled, are readily available. The available fermentation scales vary from 100L to 500L, 1000L, to 2000L. Filling volumes vary from 1ml to 25ml. Syringes or cartridges pre-filled are filled with the equivalent of 1-3ml. Our cGMP-compliant production facility ensures the availability of stable clinical samples and commercial products. The big molecules that are produced at our plant are readily available for international delivery.

• Sistema di qualità e conformità normativa globale

  Yaohai BioPharma, a top 10 Microbial CDMO, integrates quality and regulatory matters. We have a quality system that is fully compliant with the current GMP standards, as well as international regulations. Our team of regulatory experts has a deep understanding of world-wide regulatory frameworks. This lets us accelerate biological launches. We are able to guarantee traceable production procedures and high-quality products that conform with regulations from the US FDA, Tri-specific VHH Production, Australia TGA, and China NMPA. Yaohai BioPharma has successfully passed an on-site audit conducted of the European Union's Qualified Person (QP) for our GMP quality system and production site. We also have been through the initial certification audits of the ISO9001 Quality Management System and ISO14001 Environmental Management System.

• Competenza professionale e vasta esperienza

  Yaohai Bio-Pharma is a leading Microbial biologics CDMO. We have been focused on microbial-produced therapeutics and vaccines for human, veterinary, and the management of pet health. We are equipped with Tri-specific VHH Production RD platforms as well as manufacturing technology that encompass the entire process beginning with the development of microbial strains cells, methods and processes, to commercial and clinical manufacturing which ensures successful implementation of cutting-edge solutions. We have acquired a large amount of experience in bio processing of microbial cells. We have delivered over 200 global projects, and help our clients with navigating the laws from the US FDA, EU EMA, Australia TGA, and China NMPA. Our professional expertise and extensive experience allows us to quickly respond to market demands and provide tailored CDMO services.

Categorie di prodotti correlati

• Produzione di plasmidi AAV
• Metodi analitici per il DNA plasmidico
• Produzione di batteriofago AP205 VLP
• Produzione di batteriofago Q VLP
• Produzione del vaccino chimerico VLP
• Produzione di vaccini VLP coniugati
• Produzione di vaccini a DNA
• Fermentazione di E. coli per la produzione di VLP
• Produzione di agonisti GLP-1
• Produzione analogica GLP-1

Non trovi quello che cerchi?
Contatta i nostri consulenti per ulteriori prodotti disponibili.